SCHEMBL21964

SCHEMBL21964

CCc1cc(C2CCC(O)(CO)CC2)nc2c(-c3ccc(-c4ccccc4)nc3)cnn12

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHEK1 O14757 3/20 0.42
CCNA2 P20248 2/20 0.42
CDK2 P24941 2/20 0.42
CCNA1 P78396 2/20 0.42
MAPT P10636 9/20 0.40
RAB9A P51151 7/20 0.40
NPC1 O15118 6/20 0.40
SMN1; SMN2 Q16637 4/20 0.40
L3MBTL1 Q9Y468 3/20 0.40
STAT1 P42224 2/20 0.38
MTOR P42345 3/20 0.38
RPTOR Q8N122 3/20 0.38
MLST8 Q9BVC4 3/20 0.38
MAPK1 P28482 4/20 0.37
MEN1 O00255 3/20 0.37
KMT2A Q03164 3/20 0.37
TDP1 Q9NUW8 3/20 0.37
KDM4E B2RXH2 4/20 0.37
ALDH1A1 P00352 4/20 0.37
HPGD P15428 4/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17850058 0.80 CHEK1 (0.49) CHEK1CCNA2CDK2CCNA1MAPT
SCHEMBL22758 0.79 DGAT1 (0.38) CHEK1CCNA2CDK2CCNA1MAPT
SCHEMBL15031603 0.79 DGAT1 (0.38) CHEK1CCNA2CDK2CCNA1MAPT
SCHEMBL15007079 0.79 DGAT1 (0.38) CHEK1CCNA2CDK2CCNA1MAPT
SCHEMBL22763 0.79 DGAT1 (0.42) CHEK1CCNA2CDK2CCNA1MAPT
SCHEMBL18721 0.78 CHEK1 (0.47) CHEK1CCNA2CDK2CCNA1MAPT
SCHEMBL15007234 0.77 MTOR (0.42) CHEK1CCNA2CDK2CCNA1MAPT
SCHEMBL21487 0.77 MTOR (0.42) CHEK1CCNA2CDK2CCNA1MAPT
SCHEMBL20915 0.77 MTOR (0.42) CHEK1CCNA2CDK2CCNA1MAPT
SCHEMBL30996 0.77 DGAT1 (0.37) CHEK1CCNA2CDK2CCNA1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012027236-A1 NOVEL PYRAZOLO[1,5-a]PYRIMIDINE DERIVATIVES AS mTOR INHIBITORS SCHERING CORPORATION (US) 2012-03-01 WO disclosed